Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

CUSIP: 921659108

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / Common Stock
Shares outstanding
59,119,327
Total 13F shares
40,872,797
Share change
+1,127,047
Total reported value
$621,278,889
Put/Call ratio
796%
Price per share
$15.20
Number of holders
125
Value change
+$12,023,355
Number of buys
60
Number of sells
66

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
7.5%
4,461,931
$79,867,000 30 Sep 2017
13F
Palo Alto Investors LP
13F
Company
7%
4,155,670
$74,386,000 30 Sep 2017
13F
VANGUARD GROUP INC
13F
Company
4.7%
2,774,367
$49,662,000 30 Sep 2017
13F
MACQUARIE GROUP LTD
13F
Company
3.2%
1,890,085
$33,833,000 30 Sep 2017
13F
STATE STREET CORP
13F
Company
2.8%
1,648,632
$29,507,000 30 Sep 2017
13F
ARMISTICE CAPITAL, LLC
13F
Company
2.6%
1,532,000
$27,423,000 30 Sep 2017
13F
FMR LLC
13F
Company
2.5%
1,484,371
$26,570,000 30 Sep 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
2.4%
1,440,761
$25,790,000 30 Sep 2017
13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.
13F
Company
2.2%
1,312,334
$23,491,000 30 Sep 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2.1%
1,218,250
$21,807,000 30 Sep 2017
13F
MORGAN STANLEY
13F
Company
1.8%
1,084,722
$19,416,000 30 Sep 2017
13F
Avoro Capital Advisors LLC
13F
Company
1.7%
988,270
$17,690,000 30 Sep 2017
13F
ORBIMED ADVISORS LLC
13F
Company
1.6%
967,859
$17,325,000 30 Sep 2017
13F
CITADEL ADVISORS LLC
13F
Company
1.3%
790,385
$14,148,000 30 Sep 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
1.2%
696,338
$12,464,000 30 Sep 2017
13F
NORTHERN TRUST CORP
13F
Company
1%
591,786
$10,593,000 30 Sep 2017
13F
PRUDENTIAL FINANCIAL INC
13F
Company
1%
588,978
$10,543,000 30 Sep 2017
13F
AJO, LP
13F
Company
0.85%
503,255
$9,008,000 30 Sep 2017
13F
GREAT POINT PARTNERS LLC
13F
Company
0.84%
497,531
$8,906,000 30 Sep 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.8%
472,516
$8,459,000 30 Sep 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.72%
426,108
$7,628,000 30 Sep 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.72%
426,011
$7,625,000 30 Sep 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.72%
424,887
$7,605,000 30 Sep 2017
13F
BAKER BROS. ADVISORS LP
13F
Company
0.72%
423,884
$7,588,000 30 Sep 2017
13F
Invesco Ltd.
13F
Company
0.69%
409,835
$7,336,000 30 Sep 2017
13F
Spark Investment Management LLC
13F
Company
0.6%
354,400
$6,343,000 30 Sep 2017
13F
BOGLE INVESTMENT MANAGEMENT L P /DE/
13F
Company
0.6%
352,604
$6,311,000 30 Sep 2017
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
0.59%
348,350
$6,235,000 30 Sep 2017
13F
QS Investors, LLC
13F
Company
0.57%
335,426
$6,004,000 30 Sep 2017
13F
Numeric Investors LLC
13F
Company
0.56%
331,700
$5,937,000 30 Sep 2017
13F
Stonepine Capital Management, LLC
13F
Company
0.51%
300,000
$5,370,000 30 Sep 2017
13F
SEI INVESTMENTS CO
13F
Company
0.45%
267,671
$4,792,000 30 Sep 2017
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
0.41%
243,971
$4,367,000 30 Sep 2017
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.39%
229,677
$4,111,000 30 Sep 2017
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.36%
213,898
$3,829,000 30 Sep 2017
13F
Cortina Asset Management, LLC
13F
Company
0.36%
212,503
$3,804,000 30 Sep 2017
13F
D. E. Shaw & Co., Inc.
13F
Company
0.35%
206,293
$3,693,000 30 Sep 2017
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.34%
203,958
$3,651,000 30 Sep 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.34%
203,817
$3,646,000 30 Sep 2017
13F
Bank of New York Mellon Corp
13F
Company
0.34%
199,577
$3,573,000 30 Sep 2017
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.32%
191,284
$3,425,000 30 Sep 2017
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.3%
176,165
$3,180,000 30 Sep 2017
13F
University Of Notre Dame du Lac
13F
Individual
0.27%
157,781
$2,824,000 30 Sep 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.26%
151,693
$2,715,000 30 Sep 2017
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.26%
151,300
$2,708,000 30 Sep 2017
13F
Quantitative Investment Management, LLC
13F
Company
0.25%
146,200
$2,616,000 30 Sep 2017
13F
Gotham Asset Management, LLC
13F
Company
0.24%
142,159
$2,545,000 30 Sep 2017
13F
Foundry Partners, LLC
13F
Company
0.23%
138,446
$2,478,000 30 Sep 2017
13F
AXIOM INVESTORS LLC /DE
13F
Company
0.23%
137,167
$2,455,000 30 Sep 2017
13F
Allianz Asset Management GmbH
13F
Company
0.23%
133,822
$2,395,000 30 Sep 2017
13F

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q4 2017

As of 31 Dec 2017, Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by 125 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 40,872,797 shares. The largest 10 holders included BlackRock Inc., Palo Alto Investors, LLC, Vanguard Group Inc, ARMISTICE CAPITAL, LLC, MACQUARIE GROUP LTD, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, venBio Select Advisor LLC, ROTHSCHILD ASSET MANAGEMENT INC, and FMR LLC. This page lists 125 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders
137
Q4 2017 holders
125
Holder diff
-12
Investor Q3 2017 Shares Q4 2017 Shares Share Diff Share Chg % Q3 2017 Value $ Q4 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.